INCRUSE ELLIPTA 62.5 MCG INH

umeclidinium
$11.3070per EA

Strength

62.5 ug/1

NDC

00173087310

Classification

Brand

Dosage Form

AEROSOL, POWDER

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

UMECLIDINIUM BROMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA205382

On Market Since

4/30/2014

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.1%

3Y

-0.1%

5Y

-0.1%

All

+57.0%

Generic Alternatives

Save up to 9%

1 alternative • Same active ingredient